When Greg Boss joined Australian vaccination and blood plasma maker CSL in 2001, he was its only U.S. lawyer.

Two decades later, he is executive vice president for legal and group general counsel at CSL Limited – a A$146 billion (US$101 billion) company—overseeing a staff of more than 200.